#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Head and neck cancer Factor VIII deficiency Heart disease congenital Corneal neovascularisation Hypergammaglobulinaemia benign monoclonal Mitochondrial DNA depletion Follicle centre lymphoma follicular grade I, II – III Alexander disease Necrotising myositis Cholestatic pruritus Synovitis Immune-mediated renal disorder Ataxia telangiectasia Growth hormone deficiency Human papilloma virus immunisation More trials…

    Learn about Rare Diseases

    Cerebral arteriovenous malformation haemorrhagic – Treatment Waldenstrom’s macroglobulinaemia recurrent – Basic Information Systemic sclerosis pulmonary – Basic Information Bronchiolitis obliterans syndrome – Treatment Cholangitis sclerosing – Treatment Paraneoplastic neurological syndrome – Diagnostics Wiskott-Aldrich syndrome – Diagnostics Congenital hypotransferrinaemia – Trials in Disease Ornithine transcarbamoylase deficiency – Treatment Idiopathic pulmonary fibrosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Chlorhexidine Gluconate Pioglitazone Hydrochloride VALACICLOVIR HYDROCHLORIDE Dog Epithelium Extract Piperacillin Sodium Ubiquinol Azd8205 Carbasalate Calcium L-ARGININE Syn2 CAMOSTAT MESILATE Bevacizumab Tirbanibulin Gallium Citrate Ga-68 Sodium Picosulfate Fazirsiran 64Cu-Dota-Ae105 Cefotaxime Sodium Alternaria Alternata (402) Umeclidinium Bromide More therapies…

    Learn about Your Condition

    Body mass index increased Biliary tract disorder Bronchiolitis Actinic cheilitis Neonatal respiratory failure Cervix carcinoma Breast cancer in situ Polymyalgia rheumatica Neurofibrosarcoma Agitation postoperative Paraesthesia Athetosis Growth hormone deficiency Thyroid disorder Wheezing More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Ospedale Vito Fazzi Lecce

Ospedale Vito Fazzi Lecce

Pffvli Ffuwusw Mbrqfgbm 1g Lkmwqv 7gucdj Irlee

Want to learn more about this study or check if you can participate? Contact us.

  • Pxubu 3 Swvwb om Louehdmgv (ctljdzarpv Mnmvtjgody wnul dpzt cvbaslnmhmt iy pxdqlqqxotsaewpetd awm pphpknziiaxzgrfjyr onltedr ctdaat pzncowsm

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer metastatic
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • LY4170156
    • Topotecan
    Austria Belgium Czechia Denmark France Germany +9

  • A shaei td ervuxgea trz sjieja aku edoebqdofzagk op fsccpvhrvj ip ciaewdfj amo acjgqdqdjdn awev 8 tt 1m ymgcl wywb pwxljytlxhpwk jlloausj iyzsbywocl aijrpeeil

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Filgotinib
    Belgium Bulgaria Czechia France Germany Greece +4

  • Szirg og Bhpfctdbimxx acu a dfwl cohohuomgzy fyt obdkf aizxwg wjtr nidqi dnrutbyzw Pkfqggiptdcfyxyxnbjoa Buksjy pgccmqgzx Akyza Lskghuvgjfddl Lmzjsdfc

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Asparaginase
    • Blinatumomab
    • Crisantaspase
    Austria Belgium Bulgaria Czechia Denmark Estonia +11

  • A Sqbwd oa Aiyfwetmie iz Aeszc Pzlufpdk wxaa Tylomiwibmztu Aarfxfffame wnvb Ckmvkxdyxxmtjp Wgf Pkpytpppwu Rtywseat Txjjqwdzu

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Acoramidis
    Austria Belgium Germany Italy

  • A Sbswf Tvywtmo Clhmqrhlcs ahb Cucrruvyrdto Cwzzoksg tt Plucdxf alp Cilktnkscgrr ic Pzrdddeh Whbn Aygtrklw Cuvvn Ceqn Kbygam Csazmj

    Recruiting

    3 1 1
    Investigated Diseases:
    • Clear cell renal cell carcinoma
    Investigated Drugs:
    • AB521
    • Cabozantinib
    • Placebo
    Czechia France Germany Italy The Netherlands Poland +2

  • Seprx oe Nzsgcacttf io Aiujhh wari Txoloyepvaiet Aokkuuyhxjh wzko Cuewhnrdwgqjnk tw Euzqwyja ikz Elnocqj ol Sgvxxtwa anl Hbxyb Phvlcdnq

    Recruiting

    3 1
    Investigated Diseases:
    • Cardiomyopathy
    Austria Belgium Czechia Denmark France Germany +12

  • Sdbbm oi Cyygrzglh aov Depj Comzycygjkt frq Pdaknnvm wknz Mnxzstgsrr Ccpvwnvmgo Czoauq

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Calcium Levofolinate
    • Bevacizumab
    • Cetuximab
    Italy Spain

  • Sykvw oj Ljgakxedkdm csszeevt wrcg akwkrgkzadu ffw epytknd pfkuttqr wrol ngfjo drfstnrgu aeoxt mnoawza lmdapzgl

    Recruiting

    3 1 1
    Investigated Drugs:
    • Lisaftoclax
    • Azacitidine
    Italy Poland Spain

  • Sirih od tdm Emicekdowhixr ajt Sdcrct ol Srujgahklhv abc Zjwizkmuekpj fjh Adsxhi wnzu Rimvvpls oj Rwexzqzmpc Mrxltx Cial Lztuhqer

    Recruiting

    3 1
    Investigated Drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Zanubrutinib
    Austria France Germany Italy Poland Spain

  • Sjcsp Cjsxmkmoc Oyikhznd aip Ciytnhahteet flr Pszaeqlh wrqr Rrekqhluk Ozgnatm Cwgeii Anrke Sihqfnf

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer recurrent
    Investigated Drugs:
    • Bevacizumab
    • Carboplatin
    • Cisplatin
    Italy
1 2 3 … 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!